Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
Christy C. Ong(Gene Therapy Laboratory), Klaus P. Hoeflich(Pivot), Victoria Tran, Helen Turley(John Radcliffe Hospital), Marcia Belvin(CytomX Therapeutics (United States)), Hartmut Koeppen, Domagoj Vucic(University of Slavonski Brod), Peter M. Haverty, Adrian L. Harris(University of Oxford), Lori S. Friedman, Wei Zhou(Broad Institute), Tom Truong, Elizabeth M. Blackwood, Adrian M. Jubb(Allogene Therapeutics (United States))
Cited by 256
Related Papers
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
|The Lancet Oncology|2015|1.6k